Illumina, Inc. (NASDAQ: ILMN) is a Leading Gainer in Monday Morning Trading

Illumina, Inc. (NASDAQ: ILMN) is one of today’s top gainers. The company’s shares are currently up 20.58% on the day to $233.94.

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, and instrument service contracts.

So far today, approximately 2.73M shares of Illumina, Inc. have been exchanged, as compared to an average 30-day volume of 1.2M shares.

Illumina, Inc. share prices have moved between a 52-week high of $371.16 and a 52-week low of $173.45. The stock has moved -6.93% over the past week.

Mentions of Illumina, Inc. on Twitter have totaled 339 in the past 24 hours, as compared to 33 in the prior 24 hours (a change of 927.27%).

To learn more about Illumina, Inc., visit the company’s website at

Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts

To stay connected with our complimentary IBN Spotlights, please visit

About IBN

IBN consists of financial brands introduced to the investment public over the course of 17+ years. With IBN, we have amassed a collective audience of millions of social media followers. These distinctive investor brands aim to fulfill the unique needs of a growing base of client-partners. IBN will continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.

Through our Dynamic Brand Portfolio (DBP), IBN provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) Press Release Enhancement to ensure maximum impact; (4) full-scale distribution to a growing social media audience; (5) a full array of corporate communications solutions; and (6) total news coverage solutions.

For more information, please visit

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published:


Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.